About Quiver Bioscience
Quiver Bioscience is a company based in Cambridge (United States) founded in 2013 by Paul Roma, Graham Dempsey, and David Margulies was acquired by Exponential Capital in July 2023.. Quiver Bioscience offers products and services including Drug Discovery Platform, Cellular Models, and AI Analytics. Quiver Bioscience operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others.
- Headquarter Cambridge, United States
- Founders Paul Roma, Graham Dempsey, David Margulies
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$2.15 M (USD), Grant
Jul 01, 2025
-
Investors
NIH
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Exponential Capital
(Jul 06, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Quiver Bioscience
Quiver Bioscience offers a comprehensive portfolio of products and services, including Drug Discovery Platform, Cellular Models, and AI Analytics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for identifying therapeutic targets in neurological diseases.
Tools for producing neurons to analyze brain cell functions.
System to extract insights from cellular data for drug optimization.
Funding Insights of Quiver Bioscience
- Total Funding Total Funding
- Total Rounds 15
- Last Round Grant — $2.1M
-
First Round
First Round
(01 Apr 2014)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2025 | Amount | Grant - Quiver Bioscience | Valuation |
investors |
|
| Sep, 2022 | Amount | Grant - Quiver Bioscience | Valuation |
investors |
|
| Jul, 2021 | Amount | Grant - Quiver Bioscience | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Quiver Bioscience
Quiver Bioscience has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and Exponential Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location | |
|
Exponential Capital is engaged in healthcare technology venture investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Quiver Bioscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Quiver Bioscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Quiver Bioscience Comparisons
Competitors of Quiver Bioscience
Quiver Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Quiver Bioscience
Frequently Asked Questions about Quiver Bioscience
When was Quiver Bioscience founded?
Quiver Bioscience was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Quiver Bioscience located?
Quiver Bioscience is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
What does Quiver Bioscience do?
Quiver Bioscience was founded in 2013 and is based in Cambridge, United States. Medicines for neurological disorders are developed through a proprietary platform that integrates advanced human cellular models, measurement engineering, artificial intelligence, and machine learning. The lead candidate, UBE3A, targets seizure and neurodevelopment disorders. Operations focus on drug discovery in the biotechnology sector.
Who are the top competitors of Quiver Bioscience?
Quiver Bioscience's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.
What products or services does Quiver Bioscience offer?
Quiver Bioscience offers Drug Discovery Platform, Cellular Models, and AI Analytics.
Who are Quiver Bioscience's investors?
Quiver Bioscience has 3 investors. Key investors include NIH, HHS, and Exponential Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.